Lophanthoidin B exhibits significant anti-inflammatory activity by inhibiting the production of pro-inflammatory mediators such as nitric oxide and cytokines in cellular models. It has been studied for its potential in managing chronic inflammatory conditions. Additionally, it shows moderate cytotoxic effects against certain cancer cell lines, suggesting possible use in anticancer research. Its ability to modulate cellular signaling pathways, particularly those involving NF-κB, makes it a candidate for further investigation in drug development. Research is ongoing to evaluate its bioavailability and therapeutic efficacy in vivo.